BETH BERGMAN: Open Payments
NPI 1891901781 · GLENDORA, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 17 payments from 8 companies in 2025. Trend: 2023 $190 · 2024 $362 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $61 |
| PFIZER INC. | 3 | $54 |
| ABBVIE INC. | 3 | $49 |
| Amgen Inc. | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Lilly USA, LLC | 2 | $33 |
| Exact Sciences Corporation | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
Products named: Veozah, PREVNAR 20, REPATHA, SHINGRIX, MOUNJARO, UBRELVY, Cologuard Collection Kit, AIRSUPRA.
Industry payments across NJ — which companies pay providers there.
